Search Results

1328 results

  1. TSRC, Tob. Sci. Res. Conf., 2023, 76, Intro (Symposium Harm Reduction)

    Symposium: Looking forward - the challenges and opportunities ahead for harm reduction

    TAYYARAH R.(1) (Chair); TAYLOR B.(2); CECIL T.(3); MURILLO J.(4); KOVACEVIC P.(5)
    (1) Labstat International Inc., Kitchener, ON, Canada; (2) Altria Client Services, Richmond, VA, USA; (3) Food and Drug Administration, Washington, DC, USA; (4) Juul Labs, Inc, Washington, DC, USA; (5) Cryomass Technologies Inc, Denver, CO, USA
    In the year since TSRC marked its Diamond Jubilee, we have seen an unprecedented level of activity concerning regulatory mile-markers and challenges in the tobacco industry. In the United States, the FDA Center for Tobacco Products has issued...
  2. TSRC, Tob. Sci. Res. Conf., 2023, 76, abstr. 05 (also presented at CORESTA SSPT2023)

    Chemical, pharmacological, and toxicological assessment of 6-methylnicotine

    CHEETHAM A.(1); PLUNKETT S.(1); McFADDEN L.(1); SCIAN M.(1); MARKING S.(2); COFFA B.(2); CAMPBELL P.(2); GILLILAND S., III(2)
    (1) Enthalpy Specialty Labs, Richmond, VA, USA; (2) Consilium Sciences, Richmond, VA, USA
    There is interest in nicotine-related alkaloids for both recreational use and pharmaceutical applications such as smoking cessation and central nervous system disorders conditions such as Parkinson’s, Tourette’s, ADHD. Nicotine is one of many...